Zobrazeno 1 - 4
of 4
pro vyhledávání: '"I K, Veldhuijzen"'
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-13 (2018)
Abstract Background Increasing the proportion diagnosed with and on treatment for chronic hepatitis C (CHC) is key to the elimination of hepatitis C in Europe. This study contributes to secondary prevention planning in the European Union/European Eco
Externí odkaz:
https://doaj.org/article/84b75c7f05cd4f6b94285c0a7954236d
Autor:
S B, Willemse, D, Razavi-Shearer, F R, Zuure, I K, Veldhuijzen, E A, Croes, A J, van der Meer, D K, van Santen, J M, de Vree, R J, de Knegt, H L, Zaaijer, H W, Reesink, M, Prins, H, Razavi
Publikováno v:
The Netherlands journal of medicine. 73(9)
Prevalence of hepatitis C virus (HCV) infection in the Netherlands is low (anti-HCV prevalence 0.22%). All-oral treatment with direct-acting antivirals (DAAs) is tolerable and effective but expensive. Our analysis projected the future HCV-related dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::76b9a46c35fcb5b0503a8582bb409399
https://pubmed.ncbi.nlm.nih.gov/26582807
https://pubmed.ncbi.nlm.nih.gov/26582807
Publikováno v:
Journal of Hepatology. 32:225
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8c698d5a89e6cee5e2591c008d26f17
https://doi.org/10.1016/s0168-8278(00)81189-7
https://doi.org/10.1016/s0168-8278(00)81189-7
Publikováno v:
Epidemiology & Infection; Feb2005, Vol. 133 Issue 1, p113-119, 7p